MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • brouet alain

    France

  • Brown Reginald

    Unity Fellowship Church NYC

    United States

  • Brown Lucia

    VOCES FRENTE A LA HEPATITIS C

    Mexico

  • Brown Abby

    United States

  • Brown Lucia

    VOCES FRENTE A LA HEPATITIS C

    Mexico

  • Brown Lucía

    Voses frente a la hepatits C

    Mexico

  • Brown Heidi C

    hep Coalition

    United States

  • Brown Heidi C

    United States

  • Brown Shari

    Hep CGI

    United States

  • Brown Andrew

    Positive Haven

    Canada

  • Bru Ferran

    ASSCAT

    Spain

  • Bruggmann Philip

    Arud

    Switzerland

  • buades garau maria jesus

    amahc (asoc. mallorquina afectas hepatitis C)

    Spain

  • Buchaca Cristofol Pepita

    ASSCAT (Associació Catalana de Malalts d'Hepatitis)

    Spain

  • buchet annie

    France

  • buchwald mary

    brooklyn for peace

    United States

  • Buckner, I. Adair

    Healthcare provider and avid reader of HCV Advocates

    United States

  • Buffiere Aurélie

    Médecins du Monde Tanzania

    Tanzania

  • bulia nana

    Georgia

  • Burel Christine

    France

  • Burke Peter Harmen

    Myself

    United States

  • Burke Peter Harmen

    Human Race

    United States

  • Burkett Bruce

    Missouri Hepatitis C ALliance

    United States

  • bussiere patricia

    France

  • Busz Mac

    Mainline

    Netherlands

  • Byrne Jude

    INPUD

    Australia

  • byrne jude

    AIVL

    Australia

  • Bárcena Josem

    aesii

    Spain

  • Caballero Oller Jordi Pau

    Andorra

  • CABELGUEN Gael

    AIDES

    France

  • Cabezas Torrado Alicia

    Spain

  • Cabornero Pascual Alberto

    Spain

  • Cabrera Resendiz José Gerardo

    Red Mexicana de Personas que Viven con VIH/SIDA, A.C.

    Mexico

  • cadu cécile

    Act Up-Basel

    Switzerland

  • Cairns Grant

    Anova Health Institute

    South Africa

  • calado cristina

    Brazil

  • Calcote Patricia

    United States

  • Calderón Paz Celia

    Spain

  • Calderón Paz Celia

    individual

    Spain

  • Callender Mike

    United Kingdom

  • Calvillo leticia

    Chart

    United States

  • Calvo Garcia Fran

    CAS Teresa Ferrer IAS

    Spain

  • Campbell Hilary

    WHA

    Switzerland

  • Campbell Alisdair

    Private

    South Africa

  • Campmany Piqué Pilar

    Associació d'Hepatitis de Barcelona

    Spain

  • Camps i Torner Josep

    Spain

  • CANO ELENA

    Spain

  • canovas marcia jeane

    Brazil

  • CARCOLÉ BATET BLANCA

    Empresa de Salud Pública de Tarragona. Centro de Drogodependencias

    Spain

  • Carey Patricia

    NA

    United States